MedTrace Logo

Observational Analysis of T Cell Responses to SPIREs for Multiple Allergens in Subjects With Allergy in North America

NCT02601690 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 199

Last updated 2019-04-09

No results posted yet for this study

Summary

This is a research study intending to look at the response of a specific type of allergy cells in the blood (called T cells) to a a type of immunotherapy product known as SPIREs (Synthetic Peptide Immuno-Regulatory Epitopes), across a broad range of subjects. This is a non-interventional study in which no investigational product will be administered to any subject.

Conditions

  • Allergy

Interventions

OTHER

Blood Sampling

Sponsors & Collaborators

  • Circassia Limited

    collaborator INDUSTRY

  • Adiga Life Sciences, Inc.

    lead INDUSTRY

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-10-31
Primary Completion
2017-06-25
Completion
2017-06-25

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02601690 on ClinicalTrials.gov